Pancreatic cancer drug
A new medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, a study shows.
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.



